• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Overcoming Resistance

  Overcoming Resistance  
 

By adding amino acids to the molecule of tobramycin, researchers created a new antibiotic drug molecule, pentobra, which can punch holes in persister cell membranes to get inside to kill the bacteria.
Graphic: Dr. Andrea M. Kasko

 

The pace at which bacteria are developing resistance to antibiotics presents an urgent global-health concern. But now, an interdisciplinary team of scientists from UCLA’s California NanoSystems Institute has developed a method to re-engineer antibiotics to enhance their activity against key cells that are responsible for making bacteria resistant to new drugs.

The cells, known as persisters, slow down their metabolism and shut down their mechanisms for taking in molecules, preventing normal antibiotics from penetrating them to kill the bug. To overcome this resistance, the team, led by Gerard C.L. Wong, PhD, professor in the UCLA Department of Chemistry and Biochemistry and the Department of Bioengineering, and Andrea M. Kasko, PhD, associate professor of bioengineering, developed a method analogous to taking an ordinary car and adding high-performance parts to make a fast-and-furious street racer.

“We’re in an unsustainable race with bacteria,” Dr. Wong says. “It takes upward of $100 million to develop one antibiotic drug, and bacteria develop resistance to it within two years. This reality brought us to the idea of taking an existing antibiotic wand and renovating it to give it a new and complementary antimicrobial ability, while preserving its original ability, to make a better drug overall.”

The team began with the antibiotic tobramycin, to which many persisters are resistant. By adding amino acids to the molecule of tobramycin, they created a new antibiotic drug molecule, pentobra, which is able to punch holes in the membranes of persister cells to get inside to kill the bacteria. “Pentobra can punch enough holes in the cell membrane to kill the cell, but that may not be the most efficient way to kill a bug,” Dr. Wong says. “This antibiotic also messes up the bacteria’s ability to grow by preventing them from making more bacterial proteins.”

The synergistic one-two punch is “what makes this antibiotic so powerful and why pentobra can kill persister-cell strains 10,000-to-1-million times better than tobramycin,” Dr. Wong says.

This revolutionary process can be used to renovate other existing antibiotics to resurrect their activity against resistant bacteria and to enhance their potency. The new approach also can potentially be used to improve many new antibiotics being developed. “If someone has a drug they think has potential, with our method, they may be able to make it even more potent,” Dr. Kasko says.

“Engineering Persister-Specific Antibiotics with Synergistic Antimicrobial Functions,” ACS Nano, August 18, 2014


Previous
Neural Stem Cell Overgrowth and the Autistic Brain
Next
Teaching Blood Stem Cells to Regenerate


YOU ARE VIEWING

Winter 2015

Winter 2015
E-Brochure
Printable PDF
IN THIS ISSUE
  • The Life within Us
  • Friends in Deed
  • Screening Guidelines Miss Many Younger Post-menopausal Women
  • Brain Reboot
  • Heart’s Repair Process Points to New Treatment Strategy for Heart Attack
  • Neural Stem Cell Overgrowth and the Autistic Brain
  • Overcoming Resistance
  • Teaching Blood Stem Cells to Regenerate
  • Spinal Injury and Bladder Control
  • Today’s Lifestyle Choices May Affect Tomorrow’s Memory
  • Helping Young Lives Bloom in the Middle of the City
  • This Is Your Brain on Food
  • What Makes Us Fat?
  • Through Thick and Thin
  • Package Deal
  • Dr. Jam
  • Awards/Honors
  • In Memoriam
  • Fountain of Youth
  • In His Own Words: Erno S. Daniel, MD ’75 (RES ’78), PhD
  • A Tale of Two Brothers
  • David Geffen School of Medicine at UCLA Receives Unrestricted $50-Million Gift
  • The Sounds of Gratitude
  • A Step and a Wave to Raise Funds for Operation Mend 25 Cents at a Time
  • Edie & Lew Wasserman Building Opens in Stein Plaza
  • Party On (the Pier)!
  • Art of the Brain Fundraiser Celebrates 15 Years
  • Crusading for Brain-cancer Research
  • Gifts
  • In Memoriam
  • Appetite for Change
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth